Defective Apolipoprotein B-100Symptoms, Doctors, Treatments, Advances & More
Learn About Defective Apolipoprotein B-100
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
OHSU Hospital
Paul Duell is an Endocrinologist in Portland, Oregon. Dr. Duell is rated as an Elite provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Familial Hypercholesterolemia, Defective Apolipoprotein B-100, Homozygous Familial Hypercholesterolemia (HoFH), and Heterozygous Familial Hypercholesterolemia (HeFH).
Stanford Hospital And Clinics
Joshua Knowles is a Cardiologist in Stanford,, California. Dr. Knowles is rated as an Elite provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are High Cholesterol, Defective Apolipoprotein B-100, Homozygous Familial Hypercholesterolemia (HoFH), Heart Transplant, and Pacemaker Implantation.
Atrium Health Levine Children's HEARTest Yard Congenital Heart Center
Jacob Hartz is a Pediatrics specialist and a Pediatric Cardiologist in Charlotte, North Carolina. Dr. Hartz is rated as an Advanced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Homozygous Familial Hypercholesterolemia (HoFH), High Cholesterol, Defective Apolipoprotein B-100, Familial Hypertriglyceridemia, and Pacemaker Implantation. Dr. Hartz is currently accepting new patients.
Summary: Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improv...
Summary: This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and effectiveness of lomitapide.